Brexit

UK Life Sciences Firms Struggle in Post-Brexit War for EU…

UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from overseas. Additionally, UK firms are looking to poach EMA staff as it heads to Amsterdam…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

Euratom: Where Are We Now?

Hamid Yunis, partner and head of healthcare at the London office of international law firm, McDermott Will &…

Brexit uncertainty forces AstraZeneca to freeze investment in the UK

Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…

In Conversation

Dr. Geoffrey Guy, chairman and founder of cannabinoid medicine pioneer, GW Pharma, outlines the potential benefits that Brexit could bring to the UK’s life sciences industry and the evolution of his company. Unlike many of your peers, you are very optimistic about Brexit. What opportunities do you believe Brexit will create for Britain and the life sciences industry in the…

Steven Lynch – Managing Director, British Chamber of Commerce in China

Steven Lynch, managing director of the British Chamber of Commerce in China, introduces the Chamber’s activities…

Dominique Martin – CEO, ANSM, France

Dominique Martin, CEO of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)…

Roche boss: Brexit will make the UK less competitive

Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…

Brexit: A Serious Threat to Patients

As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are…

NEW Special Report on UK

Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…

Pfizer’s Nordkamp Takes ABPI Presidency

Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…

NHS England’s Long-Term Plan to be Funded by £20.5 Billion

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK…

Brexit and Irish Pharma

The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…